APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Morquio Syndrome Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Morquio Syndrome Treatment Industry Growth and Trends Forecast to 2032

Report ID 174014380119 December 2025113 pages

Choose your research edition.

Industry ResearchMorquio Syndrome Treatment Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Morquio Syndrome Treatment Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Morquio Syndrome Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morquio Syndrome Treatment Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Morquio Syndrome Treatment Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

According to APO Research, the global Morquio Syndrome Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Morquio Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Morquio Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Morquio Syndrome Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Morquio Syndrome Treatment market include Sanofi, Roche, Pfizer, Bayer, Shire, Sangamo Therapeutics, Lupin, JCR Pharmaceuticals and Green Cross, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Morquio Syndrome Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Morquio Syndrome Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Morquio Syndrome Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Morquio Syndrome Treatment.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Morquio Syndrome Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Morquio Syndrome Treatment Market by Company

Sanofi

Roche

Pfizer

Bayer

Shire

Sangamo Therapeutics

Lupin

JCR Pharmaceuticals

Green Cross

Genzyme Corporation,

Daiichi Sankyo

Concert Pharmaceuticals

Cipla

Cambrex Corporation

BioMarin

Alexion Pharmaceuticals

Morquio Syndrome Treatment Segment by Type

Morquio A

Morquio B

Morquio Syndrome Treatment Segment by Application

Hospital

Clinic

Others

Morquio Syndrome Treatment Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morquio Syndrome Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morquio Syndrome Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morquio Syndrome Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Morquio Syndrome Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Morquio Syndrome Treatment Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Morquio Syndrome Treatment Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Morquio Syndrome Treatment Market Share by Region (2021-2026) Table 4. Global Morquio Syndrome Treatment Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Morquio Syndrome Treatment Market Share by Region (2027-2032) Table 6. Global Morquio Syndrome Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Morquio Syndrome Treatment Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Morquio Syndrome Treatment Market Size Share by Type (2021-2026) Table 9. Global Morquio Syndrome Treatment Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Morquio Syndrome Treatment Market Size Share Forecasted by Type (2027-2032) Table 11. North America Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Morquio Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Morquio Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Morquio Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Morquio Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Morquio Syndrome Treatment Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Morquio Syndrome Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Morquio Syndrome Treatment Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Morquio Syndrome Treatment Market Size Share by Application (2021-2026) Table 24. Global Morquio Syndrome Treatment Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Morquio Syndrome Treatment Market Size Share Forecasted by Application (2027-2032) Table 26. North America Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Morquio Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Morquio Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Morquio Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Morquio Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Morquio Syndrome Treatment Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Morquio Syndrome Treatment Industry Trends Table 37. Morquio Syndrome Treatment Industry Drivers Table 38. Morquio Syndrome Treatment Industry Opportunities and Challenges Table 39. Morquio Syndrome Treatment Industry Restraints Table 40. Global Morquio Syndrome Treatment Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Morquio Syndrome Treatment Revenue Market Share by Company (2021-2026) Table 42. Global Morquio Syndrome Treatment Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Morquio Syndrome Treatment Key Company Headquarters & Area Served Table 44. Global Morquio Syndrome Treatment Company, Product Type & Application Table 45. Global Morquio Syndrome Treatment Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Morquio Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi Company Information Table 49. Sanofi Business Overview Table 50. Sanofi Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi Morquio Syndrome Treatment Product Portfolio Table 52. Sanofi Recent Development Table 53. Roche Company Information Table 54. Roche Business Overview Table 55. Roche Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Roche Morquio Syndrome Treatment Product Portfolio Table 57. Roche Recent Development Table 58. Pfizer Company Information Table 59. Pfizer Business Overview Table 60. Pfizer Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Pfizer Morquio Syndrome Treatment Product Portfolio Table 62. Pfizer Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Bayer Morquio Syndrome Treatment Product Portfolio Table 67. Bayer Recent Development Table 68. Shire Company Information Table 69. Shire Business Overview Table 70. Shire Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Shire Morquio Syndrome Treatment Product Portfolio Table 72. Shire Recent Development Table 73. Sangamo Therapeutics Company Information Table 74. Sangamo Therapeutics Business Overview Table 75. Sangamo Therapeutics Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Sangamo Therapeutics Morquio Syndrome Treatment Product Portfolio Table 77. Sangamo Therapeutics Recent Development Table 78. Lupin Company Information Table 79. Lupin Business Overview Table 80. Lupin Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Lupin Morquio Syndrome Treatment Product Portfolio Table 82. Lupin Recent Development Table 83. JCR Pharmaceuticals Company Information Table 84. JCR Pharmaceuticals Business Overview Table 85. JCR Pharmaceuticals Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. JCR Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 87. JCR Pharmaceuticals Recent Development Table 88. Green Cross Company Information Table 89. Green Cross Business Overview Table 90. Green Cross Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Green Cross Morquio Syndrome Treatment Product Portfolio Table 92. Green Cross Recent Development Table 93. Genzyme Corporation, Company Information Table 94. Genzyme Corporation, Business Overview Table 95. Genzyme Corporation, Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Genzyme Corporation, Morquio Syndrome Treatment Product Portfolio Table 97. Genzyme Corporation, Recent Development Table 98. Daiichi Sankyo Company Information Table 99. Daiichi Sankyo Business Overview Table 100. Daiichi Sankyo Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Daiichi Sankyo Morquio Syndrome Treatment Product Portfolio Table 102. Daiichi Sankyo Recent Development Table 103. Concert Pharmaceuticals Company Information Table 104. Concert Pharmaceuticals Business Overview Table 105. Concert Pharmaceuticals Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Concert Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 107. Concert Pharmaceuticals Recent Development Table 108. Cipla Company Information Table 109. Cipla Business Overview Table 110. Cipla Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cipla Morquio Syndrome Treatment Product Portfolio Table 112. Cipla Recent Development Table 113. Cambrex Corporation Company Information Table 114. Cambrex Corporation Business Overview Table 115. Cambrex Corporation Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Cambrex Corporation Morquio Syndrome Treatment Product Portfolio Table 117. Cambrex Corporation Recent Development Table 118. BioMarin Company Information Table 119. BioMarin Business Overview Table 120. BioMarin Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. BioMarin Morquio Syndrome Treatment Product Portfolio Table 122. BioMarin Recent Development Table 123. Alexion Pharmaceuticals Company Information Table 124. Alexion Pharmaceuticals Business Overview Table 125. Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Alexion Pharmaceuticals Morquio Syndrome Treatment Product Portfolio Table 127. Alexion Pharmaceuticals Recent Development Table 128. North America Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Morquio Syndrome Treatment Market Share by Country (2021-2026) Table 131. North America Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Morquio Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 133. Europe Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Morquio Syndrome Treatment Market Share by Country (2021-2026) Table 136. Europe Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Morquio Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Morquio Syndrome Treatment Market Share by Country (2021-2026) Table 141. Asia-Pacific Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Morquio Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 143. Latin America Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Morquio Syndrome Treatment Market Share by Country (2021-2026) Table 146. Latin America Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Morquio Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Morquio Syndrome Treatment Market Share by Country (2021-2026) Table 151. Middle East & Africa Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Morquio Syndrome Treatment Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Morquio Syndrome Treatment Product Image Figure 3. Global Morquio Syndrome Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Morquio Syndrome Treatment Market Size (2021-2032) & (US$ Million) Figure 5. Global Morquio Syndrome Treatment Market Share by Region: 2025 VS 2032 Figure 6. Global Morquio Syndrome Treatment Market Share by Region (2021-2032) Figure 7. North America Morquio Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Morquio Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Morquio Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Morquio Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Morquio Syndrome Treatment Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Morquio A Image Figure 13. Global Morquio A Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Morquio B Image Figure 15. Global Morquio B Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Morquio Syndrome Treatment Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Morquio Syndrome Treatment Market Share by Type 2025 VS 2032 Figure 18. North America Morquio Syndrome Treatment Market Size Share by Type (2021-2032) Figure 19. Europe Morquio Syndrome Treatment Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Morquio Syndrome Treatment Market Size Share by Type (2021-2032) Figure 21. Latin America Morquio Syndrome Treatment Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Morquio Syndrome Treatment Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Others Image Figure 28. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Morquio Syndrome Treatment Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Morquio Syndrome Treatment Market Share by Application 2025 VS 2032 Figure 31. North America Morquio Syndrome Treatment Market Size Share by Application (2021-2032) Figure 32. Europe Morquio Syndrome Treatment Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Morquio Syndrome Treatment Market Size Share by Application (2021-2032) Figure 34. Latin America Morquio Syndrome Treatment Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Morquio Syndrome Treatment Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Morquio Syndrome Treatment Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Morquio Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Morquio Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 41. Europe Morquio Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Morquio Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 44. Asia-Pacific Morquio Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Morquio Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 47. Latin America Morquio Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Morquio Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 50. Middle East & Africa Morquio Syndrome Treatment Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Morquio Syndrome Treatment Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Morquio Syndrome Treatment Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Morquio A
  • Morquio B
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sanofi
  • Roche
  • Pfizer
  • Bayer
  • Shire
  • Sangamo Therapeutics
  • Lupin
  • JCR Pharmaceuticals
  • Green Cross
  • Genzyme Corporation,
  • Daiichi Sankyo
  • Concert Pharmaceuticals
  • Cipla
  • Cambrex Corporation
  • BioMarin
  • Alexion Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Morquio Syndrome Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Morquio Syndrome Treatment Market Size by Region (2021-2032)
  5. 1.4.1 Global Morquio Syndrome Treatment Market Size by Region (2021-2026)
  6. 1.4.2 Global Morquio Syndrome Treatment Market Size by Region (2027-2032)
  7. 1.5 Key Regions Morquio Syndrome Treatment Market Size (2021-2032)
  8. 1.5.1 North America Morquio Syndrome Treatment Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Morquio Syndrome Treatment Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Morquio Syndrome Treatment Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Morquio Syndrome Treatment Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Morquio Syndrome Treatment Market Size Growth Rate (2021-2032)
2 Morquio Syndrome Treatment Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Morquio A
  3. 2.1.2 Morquio B
  4. 2.2 Global Morquio Syndrome Treatment Market Size by Type
  5. 2.2.1 Global Morquio Syndrome Treatment Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Morquio Syndrome Treatment Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Morquio Syndrome Treatment Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Morquio Syndrome Treatment Market Size by Regions
  9. 2.3.1 North America Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Morquio Syndrome Treatment Market Size Breakdown by Type (2021-2026)
3 Morquio Syndrome Treatment Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Others
  5. 3.2 Global Morquio Syndrome Treatment Market Size by Application
  6. 3.2.1 Global Morquio Syndrome Treatment Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Morquio Syndrome Treatment Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Morquio Syndrome Treatment Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Morquio Syndrome Treatment Market Size by Regions
  10. 3.3.1 North America Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Morquio Syndrome Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Morquio Syndrome Treatment Industry Trends
  2. 4.2 Morquio Syndrome Treatment Industry Drivers
  3. 4.3 Morquio Syndrome Treatment Industry Opportunities and Challenges
  4. 4.4 Morquio Syndrome Treatment Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Morquio Syndrome Treatment Revenue (2021-2026)
  2. 5.2 Global Morquio Syndrome Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Morquio Syndrome Treatment Key Company Headquarters & Area Served
  4. 5.4 Global Morquio Syndrome Treatment Company, Product Type & Application
  5. 5.5 Global Morquio Syndrome Treatment Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Morquio Syndrome Treatment Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Morquio Syndrome Treatment Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Morquio Syndrome Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Morquio Syndrome Treatment Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Roche Morquio Syndrome Treatment Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Pfizer Morquio Syndrome Treatment Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Morquio Syndrome Treatment Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Shire
  26. 6.5.1 Shire Company Information
  27. 6.5.2 Shire Business Overview
  28. 6.5.3 Shire Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Shire Morquio Syndrome Treatment Product Portfolio
  30. 6.5.5 Shire Recent Developments
  31. 6.6 Sangamo Therapeutics
  32. 6.6.1 Sangamo Therapeutics Company Information
  33. 6.6.2 Sangamo Therapeutics Business Overview
  34. 6.6.3 Sangamo Therapeutics Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Sangamo Therapeutics Morquio Syndrome Treatment Product Portfolio
  36. 6.6.5 Sangamo Therapeutics Recent Developments
  37. 6.7 Lupin
  38. 6.7.1 Lupin Company Information
  39. 6.7.2 Lupin Business Overview
  40. 6.7.3 Lupin Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Lupin Morquio Syndrome Treatment Product Portfolio
  42. 6.7.5 Lupin Recent Developments
  43. 6.8 JCR Pharmaceuticals
  44. 6.8.1 JCR Pharmaceuticals Company Information
  45. 6.8.2 JCR Pharmaceuticals Business Overview
  46. 6.8.3 JCR Pharmaceuticals Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 JCR Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  48. 6.8.5 JCR Pharmaceuticals Recent Developments
  49. 6.9 Green Cross
  50. 6.9.1 Green Cross Company Information
  51. 6.9.2 Green Cross Business Overview
  52. 6.9.3 Green Cross Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Green Cross Morquio Syndrome Treatment Product Portfolio
  54. 6.9.5 Green Cross Recent Developments
  55. 6.10 Genzyme Corporation,
  56. 6.10.1 Genzyme Corporation, Company Information
  57. 6.10.2 Genzyme Corporation, Business Overview
  58. 6.10.3 Genzyme Corporation, Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Genzyme Corporation, Morquio Syndrome Treatment Product Portfolio
  60. 6.10.5 Genzyme Corporation, Recent Developments
  61. 6.11 Daiichi Sankyo
  62. 6.11.1 Daiichi Sankyo Company Information
  63. 6.11.2 Daiichi Sankyo Business Overview
  64. 6.11.3 Daiichi Sankyo Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Daiichi Sankyo Morquio Syndrome Treatment Product Portfolio
  66. 6.11.5 Daiichi Sankyo Recent Developments
  67. 6.12 Concert Pharmaceuticals
  68. 6.12.1 Concert Pharmaceuticals Company Information
  69. 6.12.2 Concert Pharmaceuticals Business Overview
  70. 6.12.3 Concert Pharmaceuticals Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Concert Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  72. 6.12.5 Concert Pharmaceuticals Recent Developments
  73. 6.13 Cipla
  74. 6.13.1 Cipla Company Information
  75. 6.13.2 Cipla Business Overview
  76. 6.13.3 Cipla Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cipla Morquio Syndrome Treatment Product Portfolio
  78. 6.13.5 Cipla Recent Developments
  79. 6.14 Cambrex Corporation
  80. 6.14.1 Cambrex Corporation Company Information
  81. 6.14.2 Cambrex Corporation Business Overview
  82. 6.14.3 Cambrex Corporation Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Cambrex Corporation Morquio Syndrome Treatment Product Portfolio
  84. 6.14.5 Cambrex Corporation Recent Developments
  85. 6.15 BioMarin
  86. 6.15.1 BioMarin Company Information
  87. 6.15.2 BioMarin Business Overview
  88. 6.15.3 BioMarin Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 BioMarin Morquio Syndrome Treatment Product Portfolio
  90. 6.15.5 BioMarin Recent Developments
  91. 6.16 Alexion Pharmaceuticals
  92. 6.16.1 Alexion Pharmaceuticals Company Information
  93. 6.16.2 Alexion Pharmaceuticals Business Overview
  94. 6.16.3 Alexion Pharmaceuticals Morquio Syndrome Treatment Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Alexion Pharmaceuticals Morquio Syndrome Treatment Product Portfolio
  96. 6.16.5 Alexion Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Morquio Syndrome Treatment Market Size by Country (2021-2026)
  3. 7.3 North America Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Morquio Syndrome Treatment Market Size by Country (2021-2026)
  3. 8.3 Europe Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Morquio Syndrome Treatment Market Size by Country (2021-2026)
  3. 10.3 South America Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Morquio Syndrome Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Morquio Syndrome Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst